HighTower Advisors’s iRadimed IRMD Stock Holding History

HighTower Advisors’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.92M	Sell	20,056 -385	-2%	-$35.1K	﹤0.01%	1812
2026 Q1	$1.97M	Buy	20,441 +78	+0.4%	+$7.8K	﹤0.01%	1723
2025 Q4	$1.98M	Sell	20,363 -19,998	-50%	-$1.72M	﹤0.01%	1672
2025 Q3	$2.87M	Sell	40,361 -20,000	-33%	-$1.33M	﹤0.01%	1437
2025 Q2	$3.61M	Hold	60,361	–	–	﹤0.01%	1242
2025 Q1	$3.17M	Buy	60,361 +361	+0.6%	+$20.3K	﹤0.01%	1270
2024 Q4	$3.3M	Sell	60,000 -22,356	-27%	-$1.18M	﹤0.01%	1244
2024 Q3	$4.14M	Sell	82,356 -20,644	-20%	-$952K	0.01%	1107
2024 Q2	$4.53M	Sell	103,000 -113	-0.1%	-$4.81K	0.01%	1043
2024 Q1	$4.53M	Buy	+103,113	New	+$4.56M	0.01%	1013

Other funds holding IRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HighTower Advisors's IRMD Position: Q2 2026 in Review

HighTower Advisors reduced its iRadimed (IRMD) stake by 1.9% in Q2 2026, selling an estimated $35.1K and leaving 20,056 shares worth $1.92M. The position accounts for ﹤0.01% of the portfolio, ranked #1812.

HighTower Advisors first reported a position in IRMD in Q1 2024 and has held it in 10 quarters since. The position peaked at $4.53M in Q1 2024. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

HighTower Advisors held 20,056 shares of iRadimed worth $1.92M as of Q2 2026.
HighTower Advisors sold 385 iRadimed shares in Q2 2026, an estimated $35.1K.
iRadimed made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #1812 holding.
HighTower Advisors first reported a position in iRadimed in Q1 2024 and has held it in 10 quarters since.
HighTower Advisors's iRadimed position peaked at $4.53M in Q1 2024.
214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.